Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa
- 30 September 2007
- journal article
- Published by Elsevier in Infection, Genetics and Evolution
- Vol. 7 (5), 562-569
- https://doi.org/10.1016/j.meegid.2007.03.005
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- ROLES OF SPECIFIC PLASMODIUM FALCIPARUM MUTATIONS IN RESISTANCE TO AMODIAQUINE AND SULFADOXINE-PYRIMETHAMINE IN BURKINA FASOThe American Journal of Tropical Medicine and Hygiene, 2006
- Occurrence of the Southeast Asian/South American SVMNT Haplotype of the Chloroquine‐Resistance Transporter Gene inPlasmodium falciparumin TanzaniaThe Journal of Infectious Diseases, 2006
- Invasion of Africa by a single pfcrt allele of South East Asian typeMalaria Journal, 2006
- Artemisinin-based combinationsCurrent Opinion in Infectious Diseases, 2005
- Public health impact of drug resistant Plasmodium falciparum malariaActa Tropica, 2005
- Contribution of the pfmdr1 gene to antimalarial drug-resistanceActa Tropica, 2005
- Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trialThe Lancet, 2002
- A Molecular Marker for Chloroquine-Resistant Falciparum MalariaNew England Journal of Medicine, 2001
- Effects of Environment on Compensatory Mutations to Ameliorate Costs of Antibiotic ResistanceScience, 2000
- Assessment of the association between three pfmdr1 point mutations and chloroquine resistance in vitro of Malaysian Plasmodium falciparum isolatesTransactions of the Royal Society of Tropical Medicine and Hygiene, 1995